[Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004342:Drug Hypersensitivity / Q000453:epidemiology; D004926:Escherichia coli / Q000201:enzymology*; D006801:Humans; D007223:Infant; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008875:Middle Aged; D012075:Remission, Spontaneous; D014586:USSR
D001215:Asparaginase
Predvaritel'nye rezul'taty klinicheskogo izucheniia otechestvennoĭ L-asparaginazy iz E. coli.